IVF: Rega marang dodolan INVO Bioscience

Simbol lan logo merek INVO Bioscience (IVF)

The price-to-sales ratio on GURU.Markets reflects the valuation dynamics of INVO Fertility Inc (IVF), where the metric stands at 0.40. Growth is driven by the popularity of the INVOcell system and the expansion of IVF centers. A fabless model with US assembly provides operational flexibility, while streamlined aviation logistics ensure the uninterrupted delivery of compact incubators, supporting the stability of the company's market quotes.

IVF (INVO Fertility) riwayat Multiplikator P/S saka 29.04.2025 nganti 13.11.2026

Rincian analitis perusahaan INVO Bioscience, Inc. (IVF)

Analisis fundamental perusahaan:invobioscience.com IVF
Produk asli INVO Bioscience, Inc.

The P/S ratio determines the market value of a business relative to its annual sales volume, allowing for an assessment of revenue capitalization efficiency under conditions of limited liquidity. By analyzing the ratio of company value to annual revenue, an investor can see how the implementation of automated embryo monitoring systems and intelligent incubators by INVO Fertility Inc. (IVF) impacts the market valuation of the scalability of their technological solutions.

Karo sapa INVO Fertility Inc saingan

Kapitalisasi marang pendapatan bostonscientific.com BSX|Multiplikator P/S EW (Edwards Lifesciences Corporation)|ResMed Inc (RMD) - Rega marang dodolan|OmniPod - Multiplikator P/S|ZBH (Zimmer Biomet Holdings) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|ALGN - Koefisien rega marang pendapatan|GMED (Globus Medical) - Multiplikator P/S|Kapitalisasi marang pendapatan TransMedics Group Inc (TMDX)|Multiplikator P/S ATEC|Multiplikator P/S Artivion Corp (AORT)|Rasio rega marang pendapatan Enovis Corporation ENOV|integralife.com - Rasio rega marang pendapatan|ESTA: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan BBNX (Beta Bionics, Inc.)|IRMD: Multiplikator P/S|Rega marang dodolan Embecta Health (EMBC)|Rasio rega marang pendapatan Tandem Diabetes Care|AXGN - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan SIBN (SI-BONE)|Multiplikator P/S Orthofix Medical (OFIX)|Multiplikator P/S BVS (Bioventus Corp)|Koefisien rega marang pendapatan OrthoPediatrics Corp (KIDS)|TMCI - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan RxSight Inc|CLPT (ClearPoint Neuro Inc.) - Multiplikator P/S|Rega marang dodolan Stereotaxis Corporation STXS|Rasio rega marang pendapatan Neuronetics, Inc. (STIM)|sightsciences.com - Rasio kapitalisasi marang pendapatan|Orchestra BioMed, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ANIK (Anika Therapeutics Inc.)|InspireMD Corp - Multiplikator P/S|Koefisien rega marang pendapatan Jin Medical International ZJYL|vivani.com (VANI) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan XTNT|Kapitalisasi marang pendapatan NMTC|Rasio rega marang pendapatan MODD|Rasio rega marang pendapatan Myomo, Inc (MYO)|COCH - Rega marang dodolan|Vivos Therapeutics - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan NVNO|SINTX Technologies - Multiplikator P/S|Rasio rega marang dodolan TNON|LFWD: Multiplikator P/S|Rega marang dodolan Autonomix Medical (AMIX)|Rasio rega marang pendapatan Bone Biologics|AXNX: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan BIOL (BIOLASE)|Kapitalisasi marang volume dodolan DYNT|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)